Primary percutaneous coronary intervention and risk of stent thrombosis: a look beyond the HORIZON.

Suppr

超能文献

作者信息

Räber Lorenz, Windecker Stephan

出版信息

Circulation. 2011 Apr 26;123(16):1709-12. doi: 10.1161/CIRCULATIONAHA.111.023366. Epub 2011 Apr 11.

DOI:10.1161/CIRCULATIONAHA.111.023366

PMID:21482962

Abstract

摘要

相似文献

Primary percutaneous coronary intervention and risk of stent thrombosis: a look beyond the HORIZON.

Circulation. 2011 Apr 26;123(16):1709-12. doi: 10.1161/CIRCULATIONAHA.111.023366. Epub 2011 Apr 11.

Stent thrombosis: nightmare of the interventional cardiology era.支架血栓形成：介入心脏病学时代的噩梦。

Int J Cardiol. 2011 May 5;148(3):e51-2. doi: 10.1016/j.ijcard.2009.03.002. Epub 2009 Mar 12.

Optimizing the impact of primary percutaneous coronary intervention in acute myocardial infarction.

Catheter Cardiovasc Interv. 2011 Feb 1;77(2):201. doi: 10.1002/ccd.22952.

[Comment to article Acute coronary syndrome - a frequent clinical manifestation of bare metal in-stent restenosis].[关于文章《急性冠状动脉综合征——裸金属支架内再狭窄的常见临床表现》的评论]

Kardiol Pol. 2010 Jun;68(6):646-7.

[Fighting restenosis - never-ending story].

Kardiol Pol. 2010 Sep;68(9):994-5.

Periprocedural (30-day) risk of myocardial infarction after drug-eluting coronary stent implantation: a meta-analysis comparing cobalt-chromium and stainless steel drug-eluting coronary stents.药物洗脱冠状动脉支架置入术后 30 天内心肌梗死的围手术期风险：比较钴铬和不锈钢药物洗脱冠状动脉支架的荟萃分析。

EuroIntervention. 2011 Mar;6(8):1003-10. doi: 10.4244/EIJV6I8A173.

Efficacy and safety of rapamycin as compared to paclitaxel-eluting stents: a meta-analysis.与紫杉醇洗脱支架相比，雷帕霉素的疗效和安全性：一项荟萃分析。

J Invasive Cardiol. 2010 Jul;22(7):312-6.

Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarction.急性心肌梗死中紫杉醇洗脱支架与裸金属支架的比较

N Engl J Med. 2009 May 7;360(19):1946-59. doi: 10.1056/NEJMoa0810116.

Analysis of 14 trials comparing sirolimus-eluting stents with bare-metal stents.对14项比较西罗莫司洗脱支架与裸金属支架的试验进行分析。

N Engl J Med. 2007 Mar 8;356(10):1030-9. doi: 10.1056/NEJMoa067484. Epub 2007 Feb 12.

Impact of coronary artery stents on mortality and nonfatal myocardial infarction: meta-analysis of randomized trials comparing a strategy of routine stenting with that of balloon angioplasty.冠状动脉支架对死亡率和非致死性心肌梗死的影响：比较常规支架置入策略与球囊血管成形术策略的随机试验的荟萃分析。

Am Heart J. 2004 May;147(5):815-22. doi: 10.1016/j.ahj.2003.11.025.

引用本文的文献

Effect of intra-coronary administration of tirofiban through aspiration catheter on patients over 60 years with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention.通过抽吸导管冠状动脉内注射替罗非班对60岁以上接受经皮冠状动脉介入治疗的ST段抬高型心肌梗死患者的影响。

Medicine (Baltimore). 2018 May;97(21):e10850. doi: 10.1097/MD.0000000000010850.

Management of acute coronary syndromes in a developing country; time for a paradigm shift? an observational study.发展中国家急性冠状动脉综合征的管理；是时候进行范式转变了吗？一项观察性研究。

BMC Cardiovasc Disord. 2015 Oct 24;15:133. doi: 10.1186/s12872-015-0125-y.

Prognosis of primary percutaneous coronary intervention in elderly patients with ST-elevation myocardial infarction.老年ST段抬高型心肌梗死患者直接经皮冠状动脉介入治疗的预后

J Saudi Heart Assoc. 2015 Apr;27(2):85-90. doi: 10.1016/j.jsha.2014.12.002. Epub 2014 Dec 18.

Efficacy and safety of tirofiban-supported primary percutaneous coronary intervention in patients pretreated with 600 mg clopidogrel: results of propensity analysis using the Clinical Center of Serbia STEMI Register.替罗非班辅助的直接经皮冠状动脉介入治疗在接受600mg氯吡格雷预处理患者中的疗效与安全性：使用塞尔维亚STEMI注册临床中心进行倾向分析的结果

Eur Heart J Acute Cardiovasc Care. 2014 Mar;3(1):56-66. doi: 10.1177/2048872613514013. Epub 2013 Nov 21.

Usefulness of the RISK-PCI score to predict stent thrombosis in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a substudy of the RISK-PCI trial.RISK-PCI评分对ST段抬高型心肌梗死直接经皮冠状动脉介入治疗患者支架内血栓形成的预测价值：RISK-PCI试验的一项子研究

Heart Vessels. 2013 Jul;28(4):424-33. doi: 10.1007/s00380-012-0276-z. Epub 2012 Sep 14.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验